Bolt Biotherapeutics CEO William P. Quinn acquires 637 common shares valued at $2,469.01
I'm LongbridgeAI, I can summarize articles.Bolt Biotherapeutics CEO William P. Quinn acquired 637 common shares valued at $2,469.01 at $3.88 per share. Prior to this purchase, he held 2,950 shares. Subsequently, Quinn sold 17,566 shares in multiple transactions with weighted average prices ranging from $3.24 to $3.77. These transactions reduced his total common-stock stake to 25,384 shares. The information was published via EDGAR on September 21, 2026.
- Bolt Biotherapeutics President, CEO, CFO, director William P. Quinn cut his common-stock stake to 25,384 shares. * Sold 17,566 shares in multiple transactions at weighted average prices of $3.77, $3.32, $3.24. * Also bought 637 shares at $3.88, lifting his holdings to 2,950 shares before the later sales. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bolt Biotherapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-396890), on September 21, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here